United States: Does The Medical-School-To-Prison Pipeline Widen In Middle Age?

The trend of holding physicians personally responsible for healthcare crimes has continued unabated over the past year. As noted in a previous article, physicians are particularly attractive targets for federal prosecutors due to the "special skill" and "abuse of trust" sentencing enhancements found in the U.S. Sentencing Commission Guidelines. While measuring physician participation in illegal activity is difficult, a review of U.S. Department of Justice (DOJ) press releases and select state prosecutions over a 12-month period shows that healthcare fraud appears to be the most popular charge. Common healthcare fraud violations committed by physicians involved lab schemes, medically-unnecessary services, false statements, fraudulent billing, patient-related offenses, kickbacks and bribes, and prescription drug schemes.

The following summarizes common violations of the law by physicians charged or convicted during the past year.

Common Violations of the Law by Physicians

Age Controlled Substance Violations Money Laundering Kickbacks/ Bribes False Statements Healthcare Fraud Wire/ Mail Fraud Tax Crime
30's 3 2
40's 7 4 6 14 1 3
50's 16 4 5 6 26 2 5
60's 10 2 9 2 22 3 1
70's 6 2 4 4 2 1

Based on our review of the cases in which age information was readily available, the majority of defendants were between 50 and 70 years of age, raising the question as to whether physicians in their mid-to-late years of practice commit more fraud, and if so, why. Such findings, while arguably anecdotal in nature, point to areas where healthcare and physician organizations are at risk and yield important information for developing and fine-tuning a compliance-auditing regime. In addition, with the exception of sexual assault and similar crimes, the physicians involved tended to be associated with smaller, non-institutional practices. This could be an indicator of the need for improved and continuous compliance training for physicians in smaller practices as they approach the midpoint of their careers and beyond.

The DOJ routinely emphasizes taking "a hard look" at internal business practices in an effort to identify risk and responsible individuals. To that end, providers should remain abreast of evolving risks and circumstances. The following survey of some of the reported physician criminal cases during the past year, largely from the DOJ press reports, provides useful examples of the types of activities that have landed physicians in prison.


Involving 28 physicians, the Biodiagnostic Laboratory Services referral kickback case is believed to comprise the largest number of medical professionals ever prosecuted in a kickback case. Biodiagnostic Laboratory paid kickbacks to the physicians directly in some cases and disguised as bogus lease and service agreements in others. The physicians have pleaded guilty to varying charges that have included money laundering, bribery, kickbacks, wire fraud, tax crimes and other violations. Prison sentences imposed on the physicians ranged from one to over three years.

Clinic medical director Henry Lora, M.D., 51, admitted that in exchange for bribes and kickbacks, he and his co-conspirators wrote prescriptions for home healthcare and other services for Medicare beneficiaries that were not medically necessary or not provided, and that they falsified patient records to make it appear as if the beneficiaries qualified for these services. Lora was sentenced to 108 months in prison and ordered to pay $30.3 million in restitution and to forfeit the same amount on his conviction on one count of conspiracy to commit healthcare fraud and one count of conspiracy to defraud the United States.

Rita Luthra, M.D., 64, a gynecologist, was indicted for allegedly accepting free meals and speaker fees from a pharmaceutical company in return for prescribing the company's osteoporosis drugs, for allowing pharmaceutical sales representatives to access patient records and for lying to federal investigators. A pharmaceutical manufacturer allegedly paid Luthra $23,500 to prescribe its drugs. The payments consisted of: (1) a pharmaceutical representative bringing food to Luthra's medical office 31 times and paying Luthra $750 to talk with her for 25-30 minutes while she ate, (2) catering a barbecue that Luthra hosted at her home for her friends, and (3) $250 for speaker training for Luthra, despite the fact that Luthra never spoke to any other physicians. The government alleged that Luthra's prescriptions of the company's drugs increased during the time she was paid by the company, and precipitously declined after the company stopped paying her. Luthra also allowed a PhARMA sales representative to access protected health information in her patients' medical files and provided false information to federal agents when interviewed about her relationship with the manufacturer, and allegedly directed one of her employees to also lie to investigators.

Dr. Elena Polukhin, 58, was indicted for accepting kickbacks in exchange for referring patients to a pharmacy. At Polukhin's request, the kickbacks from the pharmacy were made payable to the Roife-Nissenbaum Trust (RN Trust), a 501(c)(3) charitable trust founded by Polukhin, who also served as its chair of the board and president. The RN Trust purportedly supported several programs and services, including scholarships to students, a directory of medical providers, fitness programs, humanitarian missions and international collaborations, a mental health and chemical dependency program, medical research, and a "starving artist's project."

False Statements

Dr. Jasminka Kostic, 59, was indicted for knowingly making false statements in a document submitted to the U.S. Citizenship and Immigration Services by falsifying medical certifications to help applicants bypass tests for U.S. citizenship. The certification provided a false length of time in which a medical examination was allegedly rendered to the applicant, and a false description of the clinical methods used to diagnose the purported impairments.

Prescription Drug Schemes

In a case deemed by the DOJ as "the first in the nation involving an organized scheme to defraud government health care programs through fraudulent claims for expensive anti-psychotic medications," Dr. Kenneth Johnson, 49, was sentenced to nine years in prison for pre-signing prescription pads used by employees of Manor Medical Imaging to generate thousands of prescriptions for vulnerable identity theft victims (e.g., elderly Vietnamese beneficiaries of Medicare and Medi-Cal, military veterans recruited from drug rehab programs, and denizens of Skid Row). After the prescriptions were filled and paid for by the Medicare and Medi-Cal programs, they were sold on the black market and redistributed to pharmacies, where the drugs would be rebilled as new claims made to Medicare and Medi-Cal.

Medically Unnecessary Services

Neurosurgeon Aria O. Sabit, 39, pleaded guilty to four counts of healthcare fraud, one count of conspiracy to commit healthcare fraud and one count of unlawful distribution of a controlled substance. Sabit admitted to investing in a physician-owned distributorship (POD) and participating in an illegal kickback scheme that required the hospitals and surgical centers where he and his fellow neurosurgeons performed surgeries to purchase spinal implant devices from the POD. The physician admitted that his involvement in the POD caused him to perform medically-unnecessary spine surgeries on some of the patients and to "over instrument" his patients (using more spinal implant devices than were medically necessary to treat his patients) in order to generate sales revenue for the POD.

Farid Fata, M.D., 50, was sentenced to serve 45 years in prison and ordered to forfeit $17.6 million for his role in a healthcare fraud scheme that included administering medically unnecessary chemotherapy infusions or injections to 553 patients and providing unnecessary positron emission tomography scans. Fata also admitted to soliciting kickbacks from a hospice and home health provider in exchange for his referral of patients.

Dermatologist Robert Kolbusz, 58, was sentenced to seven years in prison for mail fraud and wire fraud in connection with his submission of "thousands of false claims to Medicare and private insurers," for treatments to destroy pre-cancerous lesions. In reality, his patients did not have pre-cancerous lesions. Many of the treatments were performed by aestheticians in his office including cosmetic laser treatments on benign skin conditions that normally would not have qualified for insurance coverage and cosmetic procedures, such as Erbium "lunchtime laser peels." Dr. Kolbusz, in one case, billed Blue Shield to remove 491 pre-cancerous lesions from a patient when in fact he performed laser procedures to lighten her freckles.

Pain specialists Drs. John Patrick Couch, 50, and Xiulu Ruan, 53, were arrested for knowingly and willfully ordering extremely expensive secondary urine drug tests, which were billed to patients' insurance providers under the false pretense that they were necessary tests, and for distributing and dispensing Schedule II controlled substances outside the usual course of professional practice and not for a legitimate medical purpose. The indictment alleged the tests were ordered primarily because of the high reimbursement paid by insurance providers for the urine tests. The indictment further alleged that the physicians upcoded services that had been performed by physician extenders, such as nurses, using their national provider identifier numbers.

Fraudulent Billing

Pain clinic owner and operator Dr. Paramjit Singh Ajrawat, 60, was sentenced to 111 months in prison for filing claims for procedures that were not performed and for over-coding procedures, according to trial evidence. Ajrawat and his wife, Sukhveen Ajrawat, 57, a licensed psychiatrist, submitted claims for nerve block injections with the use of an imaging guidance machine, equipment they neither owned nor used. The Ajrawats also falsely documented patient files to conceal the scheme from auditors and law enforcement.

Dr. Tariq Mahmood, 63, carried out a scheme to defraud Medicare and Medicaid at hospitals he owned and operated along with others by adding, changing, and incorrectly sequencing diagnostic billing codes in a way that did not reflect the patients' actual diagnoses and condition and often did so without reviewing the medical records. He was sentenced to 135 months in federal prison and ordered to pay restitution in the amount of $599,128.02.

Dr. Dennis Barson Jr., 42, received a 10-year prison sentence for fraudulently billing for rectal sensation tests and electromyogram (EMG) studies of the anal or urethral sphincter that were never performed, and for allowing unlicensed/unsupervised personnel to treat patients and then billing it as if they had been seen by a physician.

Dr. Barry Kaplowitz, 54, was convicted of making false statements related to healthcare matters and sentenced to 60 months in prison and ordered to pay more than $2.9 million in restitution. According to evidence presented at trial, Kaplowitz, who served as the medical director at a psychiatric hospital, signed false and fraudulent medical records in order to make it appear as though the hospital's patients qualified for and had received intensive outpatient services, even though they had not. The evidence demonstrated that Kaplowitz signed patient files for over 400 patients certifying that he had treated the patients notwithstanding that he neither saw nor provided any services to these patients.

As a participant in managed care plans, Dr. Isaac Kojo Anakwah Thompson, 57, received approximately 80 percent of the capitation fee for each Medicare Advantage (MA) plan beneficiary who selected the internist as their primary care physician. To increase the capitation rate, Thompson falsely diagnosed 387 MA beneficiaries with ankylosing spondylitis. He then reported these diagnoses to the MA plan, which in turn reported them to Medicare. Consequently, Medicare paid $2.1 million in excess capitation, approximately 80 percent of which went to Thompson. All or almost all of the ankylosing spondylitis diagnoses reported by Thompson were false. Thompson pled guilty to one count of healthcare fraud and could face up to 10 years in prison.

Second-Degree Murder

Dr. Hsiu-Ying "Lisa" Tseng, 46, was sentenced to serve 30 years to life in state prison after being convicted on three counts of second-degree murder and other charges after a jury found she contributed to the deaths of three patients by prescribing large amounts of unnecessary drugs. The prosecution alleged that Tseng sometimes kept no medical records of visits or patient prescriptions and faked documentation when she was being investigated.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions